These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6146695)

  • 1. Effect of omeprazole and polyethylene glycol-400 on antipyrine elimination by the isolated perfused rat liver.
    Webster LK; Jones DB; Mihaly GW; Smallwood RA
    J Pharm Pharmacol; 1984 Jul; 36(7):470-2. PubMed ID: 6146695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of some benzimidazoles on the disposition of antipyrine and tolbutamide from the rat isolated perfused liver.
    Ward SA; Mihaly GW; Tjia JF; Back DJ
    J Pharm Pharmacol; 1985 Jan; 37(1):62-4. PubMed ID: 2858532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole: effects on oxidative drug metabolism.
    Henry DA; Somerville KW; Kitchingman G; Langman MJ
    Br J Clin Pharmacol; 1984 Aug; 18(2):195-200. PubMed ID: 6487457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of omeprazole, a potent inhibitor of gastric (H+ + K+) ATPase, on hepatic lysosomal integrity and enzyme activity.
    Grinpukel S; Sewell R; Yeomans N; Mihaly G; Smallwood R
    J Pharm Pharmacol; 1986 Feb; 38(2):158-60. PubMed ID: 2870166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hypoxia on oxidative and reductive pathways of omeprazole metabolism by the isolated perfused rat liver.
    Webster LK; Jones DB; Mihaly GW; Morgan DJ; Smallwood RA
    Biochem Pharmacol; 1985 Apr; 34(8):1239-45. PubMed ID: 3994745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of toremifene on antipyrine elimination in the isolated perfused rat liver.
    Webster LK; Ellis AG; Bishop JF
    Cancer Chemother Pharmacol; 1993; 31(4):319-23. PubMed ID: 8422697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole: effects on oxidative drug metabolism in the rat.
    Henry DA; Gerkens JF; Brent PJ; Dosen PJ
    Clin Exp Pharmacol Physiol; 1986 May; 13(5):377-81. PubMed ID: 3742882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cimetidine, ranitidine and omeprazole on hepatic flow of the artificially perfused rat liver.
    Sehayek E; Missri A; Jedwab M; Bar-Meir S
    Isr J Med Sci; 1985 Sep; 21(9):765-6. PubMed ID: 4055340
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of albumin and alpha-1 acid glycoprotein on elimination of prazosin and antipyrine in the isolated perfused rat liver.
    Oie S; Fiori F
    J Pharmacol Exp Ther; 1985 Sep; 234(3):636-40. PubMed ID: 4032284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hypoxia and pregnancy on antipyrine metabolism in isolated perfused rat livers.
    Brouwer KL; Vore M
    J Pharmacol Exp Ther; 1985 Sep; 234(3):584-9. PubMed ID: 4032283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How potent is the inhibition of drug metabolism by omeprazole?
    Webster LK; Jones DB; Smallwood RA
    Lancet; 1984 Sep; 2(8405):761. PubMed ID: 6148515
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole.
    Humphries TJ
    Dig Dis Sci; 1991 Dec; 36(12):1665-9. PubMed ID: 1748033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acid secretion inhibition with new mechanisms of action: substituted benzimidazole].
    Olbe L; Lind T; Carlsson E; Cederberg C; Helander H; Wallmark B
    Schweiz Med Wochenschr; 1984 May; 114(20):683-5. PubMed ID: 6740286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole.
    Im WB; Blakeman DP; Davis JP
    Biochem Biophys Res Commun; 1985 Jan; 126(1):78-82. PubMed ID: 2982382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of gastroprotective activity of omeprazole related benzimidazole, imidazo[4,5-b]pyridine and quinoxaline 2-substituted derivatives.
    Piras S; Loriga M; Paglietti G; Sparatore F; Demontis MP; Varoni MV; Fattaccio MC; Anania V
    Farmaco; 1993 Sep; 48(9):1249-59. PubMed ID: 8259982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
    Chindavijak B; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of omeprazole on the secretion of intrinsic factor, gastric acid and pepsin in man.
    Kittang E; Aadland E; Schjønsby H
    Gut; 1985 Jun; 26(6):594-8. PubMed ID: 3924748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.